Frontlight ResearchEarly access
CompletedPhase 3
Phase 3 Clinical Trial to Evaluate Paracetamol /Fexofenadine /Phenylephrine in Flu and Cold Treatment
Key facts
- Who runs it
- Eurofarma Laboratorios S.A.
- Where
- Brazil2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 3
- People taking part
- 567 people enrolled
- Started
- 26 Mar 2025
- Ended
- 26 Aug 2025
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Experimental drug (paracetamol 500mg / fexofenadine 60mg / phenylephrine 20mg)
- Placebo
- Record updated
- 26 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Common cold: presence of moderate to severe nasal congestion AND moderate to severe runny nose AND at least one (01) of the following moderate to severe symptoms: sneezing, headache, myalgia, sore throat, throat pain, dysphonia, cough and fever; Duration of symptoms ≤ 48 hours at screening. Informed Consent Form (ICF) signed before carrying out any study procedure
Who cannot take part
- Presence of nasal polyposis to previous rhinoscopy
- Known hypersensitivity to any component of the experimental drug formulation
- Required antibiotic therapy for upper airway infection treatment
- Presence of significant septum deviation, compatible with impaired nasal ventilatory function, at the investigator's discretion
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
A Phase 3, multicenter, Randomized, Double-blind, comparative clinical trial to evaluate the association of paracetamol 500mg + Fexofenadine 60mg + Phenylephrine 20mg in the flu and common cold treatment.
Read full original descriptionShow less
⚠️Study will only be conducted in research centers in Brazil (please do not send e-mail if your center is outside brazil).
The 2 groups in the trial
- Experimental drug (paracetamol 500mg / fexofenadine 60mg / phenylephrine 20mg)Treatment being tested
Group 1: paracetamol 500mg / fexofenadine 60mg / phenylephrine 20mg FDC (experimental drug).
- Placebo groupPlacebo, for comparison
Group 2: Placebo
Treatment: Placebo
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Multicenter, Randomized, Parallel-group, Double-blind, Comparative Trial of the Superiority of Paracetamol 500mg/Fexofenadine 60mg/Phenylephrine 20mg Fixed-dose Combination Versus Placebo in the Symptomatic Treatment of Flu and Cold
- Record updated
- 26 October 2026